Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Daniel Priksz"'
Autor:
Mohammad Walid Al-Smadi, Laszlo Adam Fazekas, Siran Aslan, Brigitta Bernat, Anas Beqain, Mustafa Qais Muhsin Al-Khafaji, Daniel Priksz, Brigitta Orlik, Norbert Nemeth
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 2970 (2023)
Arteriovenous malformation (AVM) is an anomaly of blood vessel formation. Numerous models have been established to understand the nature of AVM. These models have limitations in terms of the diameter of the vessels used and the impact on the circulat
Externí odkaz:
https://doaj.org/article/ce0dc1b3b8c04a11b013e86160d8a430
Autor:
Brigitta Bernat, Rita Erdelyi, Laszlo Fazekas, Greta Garami, Reka Maria Szekeres, Barbara Takacs, Mariann Bombicz, Balazs Varga, Fruzsina Sarkany, Arnold Peter Raduly, Dana Diana Romanescu, Zoltan Papp, Attila Toth, Zoltan Szilvassy, Bela Juhasz, Daniel Priksz
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 359 (2023)
Multi-target drug candidate BGP-15 has shown cardioprotective and antiarrhythmic actions in diseased models. Here, we investigated the effects of BGP-15 on ECG and echocardiographic parameters, heart rate variability (HRV), and arrhythmia incidence i
Externí odkaz:
https://doaj.org/article/7ca9d4e1689c4d959f45995e5fae7db7
Autor:
Mate Kozma, Mariann Bombicz, Balazs Varga, Daniel Priksz, Rudolf Gesztelyi, Vera Tarjanyi, Rita Kiss, Reka Szekeres, Barbara Takacs, Akos Menes, Jozsef Balla, Gyorgy Balla, Judit Szilvassy, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
Pharmaceutics, Vol 14, Iss 2, p 226 (2022)
Impaired mitochondrial function is associated with several metabolic diseases and health conditions, including insulin resistance and type 2 diabetes (T2DM), as well as ageing. The close relationship between the above-mentioned diseases and cardiovas
Externí odkaz:
https://doaj.org/article/59ec1d1f0609496493136e0a9a3f49f7
Autor:
Mariann Bombicz, Daniel Priksz, Rudolf Gesztelyi, Rita Kiss, Nora Hollos, Balazs Varga, Jozsef Nemeth, Attila Toth, Zoltan Papp, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
Molecules, Vol 24, Iss 3, p 586 (2019)
Background and Aims: Diabetic cardiomyopathy (DCM) is an emerging problem worldwide due to an increase in the incidence of type 2 diabetes. Animal studies have indicated that metformin and pioglitazone can prevent DCM partly by normalizing insulin re
Externí odkaz:
https://doaj.org/article/508c1c643b854f6ca9591bdf9e75b339
Autor:
Miklos Szokol, Daniel Priksz, Mariann Bombicz, Balazs Varga, Arpad Kovacs, Gabor Aron Fulop, Tamas Csipo, Aniko Posa, Attila Toth, Zoltan Papp, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
Molecules, Vol 22, Iss 10, p 1702 (2017)
The present investigation evaluates the cardiovascular effects of the anorexigenic mediator alpha-melanocyte stimulating hormone (MSH), in a rat model of type 2 diabetes. Osmotic mini pumps delivering MSH or vehicle, for 6 weeks, were surgically impl
Externí odkaz:
https://doaj.org/article/41d97ccd5fde4daa9d995c66c889e617
Autor:
Zsanett Blaga, Peter Czine, Barbara Takacs, Anna Szilagyi, Reka Szekeres, Zita Wachal, Csaba Hegedus, Gyula Buchholcz, Balazs Varga, Daniel Priksz, Mariann Bombicz, Adrienn Monika Szabo, Rita Kiss, Rudolf Gesztelyi, Dana Diana Romanescu, Zoltan Szabo, Miklos Szucs, Peter Balogh, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 20; Issue 2; Pages: 1270
The COVID-19 pandemic has posed a huge challenge to the world in recent years. The development of vaccines that are as effective as possible and accessible to society offers a promising alternative for addressing the problems caused by this situation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f4892f72d23f6b7ef10a05bbdf5fd4
Autor:
Juhasz, Mate Kozma, Mariann Bombicz, Balazs Varga, Daniel Priksz, Rudolf Gesztelyi, Vera Tarjanyi, Rita Kiss, Reka Szekeres, Barbara Takacs, Akos Menes, Jozsef Balla, Gyorgy Balla, Judit Szilvassy, Zoltan Szilvassy, Bela
Publikováno v:
Pharmaceutics; Volume 14; Issue 2; Pages: 226
Impaired mitochondrial function is associated with several metabolic diseases and health conditions, including insulin resistance and type 2 diabetes (T2DM), as well as ageing. The close relationship between the above-mentioned diseases and cardiovas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::4ac54bcfa5e52c74a34c9e696798edc8
Autor:
Mate, Kozma, Mariann, Bombicz, Balazs, Varga, Daniel, Priksz, Rudolf, Gesztelyi, Vera, Tarjanyi, Rita, Kiss, Reka, Szekeres, Barbara, Takacs, Akos, Menes, Jozsef, Balla, Gyorgy, Balla, Judit, Szilvassy, Zoltan, Szilvassy, Bela, Juhasz
Publikováno v:
Pharmaceutics. 14(2)
Impaired mitochondrial function is associated with several metabolic diseases and health conditions, including insulin resistance and type 2 diabetes (T2DM), as well as ageing. The close relationship between the above-mentioned diseases and cardiovas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19b13e4f87b24aabedd6a2aee0922cb1
https://pubmed.ncbi.nlm.nih.gov/35213959
https://pubmed.ncbi.nlm.nih.gov/35213959
Autor:
Beáta Pelles-Taskó, Réka Szekeres, Barbara Takács, Anna Szilágyi, Dóra Ujvárosy, Mariann Bombicz, Dániel Priksz, Balázs Varga, Rudolf Gesztelyi, Zoltán Szabó, Zoltán Szilvássy, Béla Juhász
Publikováno v:
Life, Vol 14, Iss 9, p 1148 (2024)
Retinal ischemia–reperfusion (I/R) injury is a critical pathogenic mechanism in various eye diseases, and an effective therapeutic strategy remains unresolved. Natural derivatives have recently reemerged; therefore, in our present study, we examine
Externí odkaz:
https://doaj.org/article/52d5878ff44c4206a3fc88b311d45bd2
Autor:
Gábor Á, Fülöp, Attila, Oláh, Tamas, Csipo, Árpád, Kovács, Róbert, Pórszász, Roland, Veress, Balázs, Horváth, László, Nagy, Beáta, Bódi, Miklós, Fagyas, Solveig Lind, Helgadottir, Viktor, Bánhegyi, Béla, Juhász, Mariann, Bombicz, Daniel, Priksz, Peter, Nanasi, Béla, Merkely, István, Édes, Zoltán, Csanádi, Zoltán, Papp, Tamás, Radovits, Attila, Tóth
Publikováno v:
Basic Research in Cardiology
Omecamtiv mecarbil (OM) is a promising novel drug for improving cardiac contractility. We tested the therapeutic range of OM and identified previously unrecognized side effects. The Ca2+ sensitivity of isometric force production (pCa50) and force at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba90f7d4b8f0f08d25e34595c4755f1a
https://pubmed.ncbi.nlm.nih.gov/33844095
https://pubmed.ncbi.nlm.nih.gov/33844095